Matthew Gantz
Directeur Général chez Castle Creek Biosciences, Inc.
Provenance du réseau au premier degré de Matthew Gantz
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.
35
| Extinct | Medical Specialties | 35 |
19
| Subsidiary | Pharmaceuticals: Major | 19 |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA.
17
| Holding Company | Biotechnology | 17 |
Marine Corps Scholarship Foundation
 Marine Corps Scholarship Foundation Investment Trusts/Mutual FundsMiscellaneous The Marine Corps Scholarship Foundation is a non-profit organization that provides financial assistance to Marines and their families for post-high school education, including undergraduate and career and technical education programs. The non-profit company is based in Alexandria, VA. The foundation aims to honor the service of Marines by helping to cover the cost of education.
16
| Non-Profit Organization | Investment Trusts/Mutual Funds | 16 |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million.
7
| Subsidiary | Biotechnology | 7 |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.
5
| Holding Company | Pharmaceuticals: Generic | 5 |
BTG International, Inc.
 BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania.
2
| Extinct | Investment Managers | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Matthew Gantz via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of California, Berkeley | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Doctorate Degree Doctorate Degree Undergraduate Degree Masters Business Admin | |
| Stanford University | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Undergraduate Degree Masters Business Admin | |
CIRC Biosciences, Inc.
 CIRC Biosciences, Inc. BiotechnologyHealth Technology CIRC Biosciences, Inc. is a privately held cell therapy company that focuses on developing treatments for serious diseases with high unmet needs. The company is based in Dallas, TX. The company's initial focus is on the eye. The company was founded by Jeffrey S. Aronin. | Biotechnology | Founder President Director/Board Member Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Director/Board Member Masters Business Admin Doctorate Degree Doctorate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chairman Chairman Chief Executive Officer | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
Paragon Biosciences Emalex Capital, Inc.
 Paragon Biosciences Emalex Capital, Inc. Pharmaceuticals: MajorHealth Technology Paragon Biosciences Emalex Capital, Inc. provides pharmaceuticals services. The company is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member | |
Paragon Biosciences Qlarity Capital, Inc.
 Paragon Biosciences Qlarity Capital, Inc. Pharmaceuticals: MajorHealth Technology Paragon Biosciences Qlarity Capital, Inc. provides pharmaceutical services. The company was founded in 2018 and is headquartered in Chicago, IL. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
Paragon Biosciences Skyline Capital LLC
 Paragon Biosciences Skyline Capital LLC Pharmaceuticals: MajorHealth Technology Paragon Biosciences Skyline Capital LLC engages in the provision of pharmaceutical services. The company is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member | |
World Business Chicago
 World Business Chicago Miscellaneous Commercial ServicesCommercial Services World Business Chicago provides economic data and statistical assistance services. The company was founded in 1999 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Cell Therapy Catapult Ltd.
 Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree Masters Business Admin | |
| United States Marine Corps | Sovereign | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| The Johns Hopkins University | College/University | Director/Board Member Undergraduate Degree Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Villanova University | College/University | Undergraduate Degree Graduate Degree | |
| Medical College of Virginia | College/University | Doctorate Degree Doctorate Degree | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree | |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Biotechnology | Director of Finance/CFO Chief Executive Officer | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
| VECTURA GROUP | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Kellogg School of Management | College/University | Director/Board Member Masters Business Admin | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Undergraduate Degree | |
| VALNEVA | Biotechnology | Director of Finance/CFO Director/Board Member | |
| XENCOR, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Uppsala | College/University | Undergraduate Degree Undergraduate Degree | |
Synpromics Ltd.
 Synpromics Ltd. Chemicals: SpecialtyProcess Industries Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom. | Chemicals: Specialty | Director/Board Member Chairman | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CONSORT MEDICAL PLC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 34 |
| Royaume-Uni | 11 |
| Suède | 3 |
| Canada | 2 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 30 |
| Consumer Services | 16 |
| Commercial Services | 3 |
| Government | 2 |
| Miscellaneous | 2 |
Opérationnelle
| Director/Board Member | 553 |
| Corporate Officer/Principal | 242 |
| Independent Dir/Board Member | 123 |
| Chief Tech/Sci/R&D Officer | 100 |
| Chairman | 97 |
Relations les plus connectées
| Insiders | |
|---|---|
| Antonio Gracias | 42 |
| Alain Munoz | 38 |
| John Brown | 36 |
| Jeffrey Aronin | 35 |
| Craig Duchossois | 34 |
| Robert Frank Agostinelli | 34 |
| Susan Foden | 32 |
| Garry Watts | 31 |
| Edward Penhoet | 29 |
| David Lawrence | 29 |
| Mike Armstrong | 28 |
| Denise O'Leary | 27 |
| Peter Chambré | 23 |
| Lewis Williams | 23 |
| David Ludvigson | 22 |
- Bourse
- Insiders
- Matthew Gantz
- Connexions Sociétés